✦ LIBER ✦

Diethylstilbestrol (DES) in hormone resistant prostate cancer (HRPC): PSA response, palliative benefit and survival

✍ Scribed by M. Shahidi; A.R. Norman; J. Gadd; J. Simpson; R.A. Huddart; A. Horwich; D.P. Dearnaley

Book ID: 117658432
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 169 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81067-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7037 Clinical, biochemical (PSA) and rad

7037 Clinical, biochemical (PSA) and radiographic benefit with sunitinib as a single agent in metastatic chemoresistant and hormone-refractory prostate cancer (HRPC) patients

✍ Castellano, D.; Larriba, J. Gonzalez; Aparicio, L.M. Antón; Casinello, J.; Grand 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

3LB ZD4054, a potent, specific endotheli

3LB ZD4054, a potent, specific endothelin A receptor antagonist, improves overall survival in pain-free or mildly symptomatic patients with hormone-resistant prostate cancer (HRPC) and bone metastases

✍ N.D. James; M. Borre; B. Zonnenberg; P. Beuzeboc; T. Morris; D. Phung; N. Dawson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 38 KB

705 ABIRATERONE ACETATE PLUS LOW-DOSE PR

705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY

✍ Saad, Fred; de Bono, Johann S.; Haqq, Christopher M.; Logothetis, Christopher J. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB